Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05343598 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

StatusRecruiting
PhaseNot applicable
Started2021-10-13
View on ClinicalTrials.gov ↗

Amendment history

2026-01-21
2 amendments v2-v3
2 re-verifications since 2024-03-11, no change to tracked fields
2022-08-10
Active, Not Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusActive, Not Recruiting→Recruiting
Study sitesdetails revised at 1 of 1 site
2022-04-20
Original filing
Mclean Hospital
53 trials monitored
See 1 trial at risk
Schizophrenia
675 trials monitored
See 32 trials at risk
This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study how hallucinations work in schizophrenia. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study the investigators will be stimulating the brain to learn more about how TMS might improve these symptoms of schizophrenia.
Trial Details
NCT Number NCT05343598
Lead Sponsor Mclean Hospital
Collaborators: Beth Israel Deaconess Medical Center, National Institute of Mental Health (NIMH)
Conditions Schizophrenia, Schizo Affective Disorder
Enrollment 68 participants
Start Date 2021-10-13
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-22